Gilead Sciences, Inc.GILDNASDAQ
Loading
Gross Profit Growth TrendStable
Percentile Rank87
3Y CAGR+21.5%
5Y CAGR+0.4%
Year-over-Year Change
Year-over-year gross profit growth rate
3Y CAGR
+21.5%/yr
Quarterly compound
5Y CAGR
+0.4%/yr
Recent acceleration
Percentile
P87
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
1 qtr
Consecutive declineStable
| Period | Value |
|---|---|
| Q4 2025 | 11.00% |
| Q3 2025 | 11.11% |
| Q2 2025 | 8.84% |
| Q1 2025 | -14.38% |
| Q4 2024 | 0.28% |
| Q3 2024 | 10.39% |
| Q2 2024 | 5.36% |
| Q1 2024 | 2.19% |
| Q4 2023 | -8.40% |
| Q3 2023 | 6.36% |
| Q2 2023 | 4.16% |
| Q1 2023 | -17.39% |
| Q4 2022 | 6.13% |
| Q3 2022 | 17.21% |
| Q2 2022 | -6.74% |
| Q1 2022 | 11.89% |
| Q4 2021 | -25.51% |
| Q3 2021 | 28.40% |
| Q2 2021 | -4.64% |
| Q1 2021 | -15.96% |
| Q4 2020 | 10.80% |
| Q3 2020 | 33.27% |
| Q2 2020 | -10.92% |
| Q1 2020 | 9.13% |
| Q4 2019 | -8.16% |
| Q3 2019 | -2.48% |
| Q2 2019 | 8.35% |
| Q1 2019 | 2.34% |
| Q4 2018 | -6.32% |
| Q3 2018 | 1.30% |
| Q2 2018 | 8.93% |
| Q1 2018 | -12.91% |
| Q4 2017 | -14.36% |
| Q3 2017 | -8.89% |
| Q2 2017 | 8.42% |
| Q1 2017 | -11.16% |
| Q4 2016 | -1.98% |
| Q3 2016 | -7.83% |
| Q2 2016 | 4.71% |
| Q1 2016 | -11.32% |